Biomarker in der Arzneimittelentwicklung

Imaging Biomarkers in Drug Development

Sheela Agarwal, Janet C. Miller and Sanjay Saini

Imaging Biomarkers in Drug Development

The price tag of drug development has steadily increased over the years with it now costing an average of $1.3 billion and ten years to bring a new drug to market. These staggering numbers play a significant role in the rising price of drugs. For example, the anti-cancer drug, bevacizumab costs about $50,000 for one year’s treatment. This contributes to the unsustainable rise in healthcare expense and leads to increasing pressure to reduce the costs of drug development.